邓军博士，男，1987年生，中共党员，主任医师，博/硕士研究生导师，南昌大学第一附属医院肿瘤中心行政副主任，美国杜兰大学访问学者。2020年入选江西省主要学科学术和技术带头人青年人才培养计划，2023年入选江西省“双千计划”人才，中国抗癌协会肺癌专业委员会委员等。主持国家自然科学基金课题3项，以第一作者或通讯作者（含共同）发表SCI论文多篇，代表作涵盖Molecular Cell，Advance Science，Cell Reports，Redox Biology，Molecular Cancer，Oncogene等期刊。

在临床方面，长期专注于消化道肿瘤及肺癌的综合诊疗，擅长放疗、化疗、免疫治疗及靶向治疗等多种精准治疗手段的综合应用。在临床转化研究方面，聚焦于胃肠道肿瘤类器官的构建与应用，探索精准治疗的最佳方案。

胃肠肿瘤的综合治疗，胃肠道肿瘤类器官的构建与应用，探索精准治疗

1. Liao Q, Deng J, Tong J, Gan Y, Hong W, Dong H, Cao M, Xiong C, Chen Y, Xie B, Yang FY, Alifu A, Zhou GB, Huang S, Xiong J, Hao Q, Zhou X. p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis. Mol Cell. 2025 Jan 2;85(1):132-149.e7. doi: 10.1016/j.molcel.2024.11.013. Epub 2024 Dec 4.

2. Liu Z, Li J, Ding Y, Ma M, Chen J, Lei W, Li L, Yao Y, Yu X, Zhong M, Liao Q, Fang W, Fan L, Huang C, Zhong H, Wen Q, Fang Z, Chen J, Huang S, Xiong J, Xiang X, Deng J. USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer. Oncogene. 2022 Apr;41(18):2555-2570.

3. Ruan R, Li L, Li X, Huang C, Zhang Z, Zhong H, Zeng S, Shi Q, Xia Y, Zeng Q, Wen Q, Chen J, Dai X, Xiong J, Xiang X, Lei W, Deng J. Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment. Mol Cancer. 2023 Mar 25;22(1):60.

4. Gan Y, Hao Q, Han T, Tong J, Yan Q, Zhong H, Gao B, Li Y, Xuan Z, Li P, Yao L, Xu Y, Jiang YZ, Shao ZM, Deng J, Chen J, Zhou X. Targeting BRIX1 via Engineered Exosomes Induces Nucleolar Stress to Suppress Cancer Progression. Adv Sci (Weinh). 2024 Dec;11(47):e2407370.

5. Gan Y, Deng J, Hao Q, Huang Y, Han T, Xu JG, Zhao M, Yao L, Xu Y, Xiong J, Lu H, Wang C, Chen J, Zhou X. UTP11 deficiency suppresses cancer development via nucleolar stress and ferroptosis. Redox Biol. 2023 Jun;62:102705. doi: 10.1016/j.redox.2023.10270

6. Huang Y, Xiong C, Wang C, Deng J, Zuo Z, Wu H, Xiong J, Wu X, Lu H, Hao Q, Zhou X. p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP. Cell Rep. 2023 Nov 28;42(11):113426.